Consolidated Statement Of Cash Flows

Astellas Pharma Inc. - Filing #7711337

Concept 2018-04-01 to
2019-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
As at
2017-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
JPY
JPY
222,265,000,000 JPY
222,265,000,000 JPY
JPY
JPY
JPY
JPY
JPY
222,265,000,000 JPY
JPY
JPY
JPY
JPY
164,679,000,000 JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
164,679,000,000 JPY
164,679,000,000 JPY
Impairment losses (reversal of impairment losses)
11,446,000,000 JPY
42,398,000,000 JPY
Decrease (increase) in inventories
-5,480,000,000 JPY
37,830,000,000 JPY
Other
20,000,000 JPY
69,723,000,000 JPY
Subtotal
328,543,000,000 JPY
377,635,000,000 JPY
Income taxes paid
-69,913,000,000 JPY
-65,021,000,000 JPY
Net cash provided by (used in) operating activities
258,630,000,000 JPY
312,614,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-25,190,000,000 JPY
-25,077,000,000 JPY
Proceeds from sale of property, plant and equipment
20,949,000,000 JPY
1,209,000,000 JPY
Purchase of intangible assets
-26,938,000,000 JPY
-15,208,000,000 JPY
Payments for acquisition of subsidiaries
-19,292,000,000 JPY
-83,723,000,000 JPY
Other
5,916,000,000 JPY
-7,818,000,000 JPY
Net cash provided by (used in) investing activities
-41,757,000,000 JPY
-121,799,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-160,442,000,000 JPY
-130,712,000,000 JPY
Other
-1,173,000,000 JPY
-1,083,000,000 JPY
Net cash provided by (used in) financing activities
-233,681,000,000 JPY
-203,429,000,000 JPY
Cash and cash equivalents
311,074,000,000 JPY
331,731,000,000 JPY
340,923,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
-2,118,000,000 JPY
3,421,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.